Acyclovir Active Pharmaceutical Ingredient (API) - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Acyclovir Active Pharmaceutical Ingredient (API) - Global Top Players Market Share and Ranking 2025

Acyclovir Active Pharmaceutical Ingredient (API) - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-28
Report Id: 2856202
Industry: Pharma & Healthcare
Report Page: 118
Chart: 111

PDF Download

Publication Date: 2025-11-28
Report Id: 2856202
Industry: Pharma & Healthcare
Report Page: 118
Chart: 111

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Acyclovir Active Pharmaceutical Ingredient (API) Definition
1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size and Forecast
1.2.1 By Consumption Value, Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
1.2.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Average Selling Price (ASP), 2020-2031
1.3 China Acyclovir Active Pharmaceutical Ingredient (API) Market Size and Forecast
1.3.1 By Consumption Value, China Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
1.3.2 By Sales Quantity, China Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
1.3.3 China Acyclovir Active Pharmaceutical Ingredient (API) Average Selling Price (ASP), 2020-2031
1.4 Share of China Acyclovir Active Pharmaceutical Ingredient (API) Market with Respect to the Global Market
1.4.1 By Consumption Value, China Acyclovir Active Pharmaceutical Ingredient (API) Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Acyclovir Active Pharmaceutical Ingredient (API) Market Share in Global, 2020-2031
1.4.3 Acyclovir Active Pharmaceutical Ingredient (API) Market Size: China VS Global, 2020-2031
1.5 Acyclovir Active Pharmaceutical Ingredient (API) Market Dynamics
1.5.1 Acyclovir Active Pharmaceutical Ingredient (API) Market Drivers
1.5.2 Acyclovir Active Pharmaceutical Ingredient (API) Market Restraints
1.5.3 Acyclovir Active Pharmaceutical Ingredient (API) Industry Trends
1.5.4 Acyclovir Active Pharmaceutical Ingredient (API) Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Acyclovir Active Pharmaceutical Ingredient (API), Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Acyclovir Active Pharmaceutical Ingredient (API), Global Market Share by Company, 2020-2025
2.3 Acyclovir Active Pharmaceutical Ingredient (API) Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Acyclovir Active Pharmaceutical Ingredient (API) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Acyclovir Active Pharmaceutical Ingredient (API) Concentration Ratio
2.6 Global Acyclovir Active Pharmaceutical Ingredient (API) Mergers & Acquisitions, Expansion Plans
2.7 Global Acyclovir Active Pharmaceutical Ingredient (API) Manufacturers Product Type
2.8 Head Office and Acyclovir Active Pharmaceutical Ingredient (API) Production Site of Key Manufacturer
2.9 Acyclovir Active Pharmaceutical Ingredient (API) Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Acyclovir Active Pharmaceutical Ingredient (API), China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Acyclovir Active Pharmaceutical Ingredient (API), China Market Share by Company, 2020-2025
3.3 China Acyclovir Active Pharmaceutical Ingredient (API) Acyclovir Active Pharmaceutical Ingredient (API) Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Capacity by Region
4.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Acyclovir Active Pharmaceutical Ingredient (API) Production by Region, 2020-2031
4.5 Global Acyclovir Active Pharmaceutical Ingredient (API) Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Acyclovir Active Pharmaceutical Ingredient (API) Industry Chain
5.2 Acyclovir Active Pharmaceutical Ingredient (API) Upstream Analysis
5.2.1 Acyclovir Active Pharmaceutical Ingredient (API) Core Raw Materials
5.2.2 Main Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Acyclovir Active Pharmaceutical Ingredient (API) Production Mode
5.6 Acyclovir Active Pharmaceutical Ingredient (API) Procurement Model
5.7 Acyclovir Active Pharmaceutical Ingredient (API) Industry Sales Model and Sales Channels
5.7.1 Acyclovir Active Pharmaceutical Ingredient (API) Sales Model
5.7.2 Acyclovir Active Pharmaceutical Ingredient (API) Typical Distributors

6 Sights by Type
6.1 Acyclovir Active Pharmaceutical Ingredient (API) Classification by Type
6.1.1 Purity 98%-99%
6.1.2 Purity ≥ 99%
6.1.3 Others
6.2 by Type, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020-2031
6.4 by Type, Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, 2020-2031
6.5 by Type, Global Acyclovir Active Pharmaceutical Ingredient (API) Average Selling Price (ASP), 2020-2031

7 Sights by Application Dosage Forms
7.1 Acyclovir Active Pharmaceutical Ingredient (API) Classification by Application Dosage Forms
7.1.1 Injection
7.1.2 Tablet
7.1.3 Capsule
7.1.4 Ointment
7.1.5 Others
7.2 by Application Dosage Forms, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application Dosage Forms, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020-2031
7.4 by Application Dosage Forms, Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, 2020-2031
7.5 by Application Dosage Forms, Global Acyclovir Active Pharmaceutical Ingredient (API) Average Selling Price (ASP), 2020-2031

8 Sights by Sales Channels
8.1 Acyclovir Active Pharmaceutical Ingredient (API) Classification by Sales Channels
8.1.1 Online Sales
8.1.2 Offline Sales
8.2 by Sales Channels, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Sales Channels, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020-2031
8.4 by Sales Channels, Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, 2020-2031
8.5 by Sales Channels, Global Acyclovir Active Pharmaceutical Ingredient (API) Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Acyclovir Active Pharmaceutical Ingredient (API) Segment by Application
9.1.1 Pharmaceuticals
9.1.2 Scientific Research
9.2 by Application, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020-2031
9.4 by Application, Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, 2020-2031
9.5 by Application, Global Acyclovir Active Pharmaceutical Ingredient (API) Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020-2031
10.3 By Region, Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Acyclovir Active Pharmaceutical Ingredient (API) Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Acyclovir Active Pharmaceutical Ingredient (API) Market Size Market Share
10.5 Europe
10.5.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Acyclovir Active Pharmaceutical Ingredient (API) Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Market Size Market Share
10.7 South America
10.7.1 South America Acyclovir Active Pharmaceutical Ingredient (API) Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Acyclovir Active Pharmaceutical Ingredient (API) Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Acyclovir Active Pharmaceutical Ingredient (API) Consumption Value, 2020-2031
11.3 By Country, Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.4.2 by Type, United States Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.5.2 by Type, Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.6.2 by Type, China Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.7.2 by Type, Japan Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.8.2 by Type, South Korea Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.10.2 by Type, India Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Zhejiang Zhebei Pharmaceuticals
12.1.1 Zhejiang Zhebei Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.1.2 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.1.3 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Zhejiang Zhebei Pharmaceuticals Company Profile and Main Business
12.1.5 Zhejiang Zhebei Pharmaceuticals Recent Developments
12.2 Hongyuan Pharmaceuticals
12.2.1 Hongyuan Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.2.2 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.2.3 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Hongyuan Pharmaceuticals Company Profile and Main Business
12.2.5 Hongyuan Pharmaceuticals Recent Developments
12.3 Xinxiang Pharmaceuticals
12.3.1 Xinxiang Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.3.2 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.3.3 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Xinxiang Pharmaceuticals Company Profile and Main Business
12.3.5 Xinxiang Pharmaceuticals Recent Developments
12.4 Hubei Yitai Pharmaceuticals
12.4.1 Hubei Yitai Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.4.2 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.4.3 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Hubei Yitai Pharmaceuticals Company Profile and Main Business
12.4.5 Hubei Yitai Pharmaceuticals Recent Developments
12.5 Zhejiang Chengyi Pharmaceuticals
12.5.1 Zhejiang Chengyi Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.5.2 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.5.3 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Zhejiang Chengyi Pharmaceuticals Company Profile and Main Business
12.5.5 Zhejiang Chengyi Pharmaceuticals Recent Developments
12.6 Shanghai Pharmaceuticals Kangli
12.6.1 Shanghai Pharmaceuticals Kangli Company Information, Head Office, Market Area, and Industry Position
12.6.2 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.6.3 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Shanghai Pharmaceuticals Kangli Company Profile and Main Business
12.6.5 Shanghai Pharmaceuticals Kangli Recent Developments
12.7 Zhejiang Chetou Pharmaceuticals
12.7.1 Zhejiang Chetou Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.7.2 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.7.3 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Zhejiang Chetou Pharmaceuticals Company Profile and Main Business
12.7.5 Zhejiang Chetou Pharmaceuticals Recent Developments
12.8 Mangalam
12.8.1 Mangalam Company Information, Head Office, Market Area, and Industry Position
12.8.2 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.8.3 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Mangalam Company Profile and Main Business
12.8.5 Mangalam Recent Developments
12.9 Vinuthana
12.9.1 Vinuthana Company Information, Head Office, Market Area, and Industry Position
12.9.2 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.9.3 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 Vinuthana Company Profile and Main Business
12.9.5 Vinuthana Recent Developments
12.10 Atom pharma
12.10.1 Atom pharma Company Information, Head Office, Market Area, and Industry Position
12.10.2 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.10.3 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 Atom pharma Company Profile and Main Business
12.10.5 Atom pharma Recent Developments
12.11 ViSTART
12.11.1 ViSTART Company Information, Head Office, Market Area, and Industry Position
12.11.2 ViSTART Acyclovir Active Pharmaceutical Ingredient (API) Models, Specifications, and Application
12.11.3 ViSTART Acyclovir Active Pharmaceutical Ingredient (API) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 ViSTART Company Profile and Main Business
12.11.5 ViSTART Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Acyclovir Active Pharmaceutical Ingredient (API) should grow from US$ 1735 million in 2024 to US$ 2421 million by 2031, with a CAGR of 4.7% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Acyclovir Active Pharmaceutical Ingredient (API)

According to YH Research, the global market for Acyclovir Active Pharmaceutical Ingredient (API) should grow from US$ 1735 million in 2024 to US$ 2421 million by 2031, with a CAGR of 4.7% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2024, global Acyclovir Active Pharmaceutical Ingredient (API) production reached approximately 200,000 tons, with an average global market price of around US$8 per kilogram. In 2024, the global 's total production capacity of Acyclovir Active Pharmaceutical Ingredient (API) reached 250,000 tons units. The industry average gross profit margin of this product reached 42%.Acyclovir active pharmaceutical ingredient (API) is a synthetic purine nucleoside analog, chemically named 9-(2-hydroxyethoxymethyl)guanine. It is a white, odorless crystalline powder and the active ingredient in antiviral drugs. As a systemic antiviral drug, it is primarily used to treat infections caused by herpes simplex virus (HSV) and herpes zoster virus (HZV), including genital herpes, herpes zoster, varicella in immunocompromised individuals, and herpes simplex encephalitis. This API works by inhibiting viral DNA replication. It requires a synthetic process and must meet strict pharmacopoeia standards and quality requirements. Downstream formulations include various dosage forms such as oral immediate-release formulations, granules, injections, and ointments.

The upstream of the acyclovir API supply chain mainly includes the supply of chemical raw materials and intermediates, such as the purine nucleoside analogs and related solvents required for synthesis. The midstream involves the production and manufacturing of the API, including synthetic processes, purification, quality control, and domestic and international registration and certification. The downstream supply chain covers formulation production, which is sold to end users through hospitals, pharmacies, and other channels for the treatment of herpes simplex virus infection, herpes zoster, and other diseases. Furthermore, the industry chain also involves import and export trade, logistics and distribution, and policy regulation. The overall structure is closely interconnected, with upstream raw material supply and downstream formulation market demand jointly driving the stable operation of the industry chain.

The acyclovir active pharmaceutical ingredient (API) market outlook is generally stable, but growth is limited. The global market is projected to maintain moderate growth between 2024 and 2031, with a certain percentage CAGR. The Chinese market is expected to increase its share driven by policy and demand. Driving factors include the continued prevalence of diseases such as herpes simplex virus, a solid global demand base for antiviral drugs, and efficiency improvements brought about by new process technologies. However, the market also faces challenges. For example, acyclovir, as a mature product, is in a highly competitive market with significant price pressure, and downstream formulation manufacturers may reduce their API purchases due to external factors such as the COVID-19 pandemic. In the future, companies need to cope with policy and regulatory changes through technological upgrades and compliant production, and explore emerging markets to maintain competitiveness. The overall market is expected to show a trend of stable volume and stable prices.

This report studies and analyses global Acyclovir Active Pharmaceutical Ingredient (API) status and future trends, helps the client to determine the Acyclovir Active Pharmaceutical Ingredient (API) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Acyclovir Active Pharmaceutical Ingredient (API), and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Acyclovir Active Pharmaceutical Ingredient (API) market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Tons)
(2) Global Acyclovir Active Pharmaceutical Ingredient (API) sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(3) China Acyclovir Active Pharmaceutical Ingredient (API) sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(4) Global Acyclovir Active Pharmaceutical Ingredient (API) key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Acyclovir Active Pharmaceutical Ingredient (API) key producing regions, capacity, production, and year over year growth
(6) Acyclovir Active Pharmaceutical Ingredient (API) industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Zhejiang Zhebei Pharmaceuticals
    Hongyuan Pharmaceuticals
    Xinxiang Pharmaceuticals
    Hubei Yitai Pharmaceuticals
    Zhejiang Chengyi Pharmaceuticals
    Shanghai Pharmaceuticals Kangli
    Zhejiang Chetou Pharmaceuticals
    Mangalam
    Vinuthana
    Atom pharma
    ViSTART

Market segment by Type, covers
    Purity 98%-99%
    Purity ≥ 99%
    Others

Market segment by Application Dosage Forms, covers
    Injection
    Tablet
    Capsule
    Ointment
    Others

Market segment by Sales Channels, covers
    Online Sales
    Offline Sales

Market segment by Application, can be divided into
    Pharmaceuticals
    Scientific Research

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Acyclovir Active Pharmaceutical Ingredient (API) product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Acyclovir Active Pharmaceutical Ingredient (API) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Acyclovir Active Pharmaceutical Ingredient (API) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Acyclovir Active Pharmaceutical Ingredient (API), percent & CAGR, 2020-2031
Chapter 5: Acyclovir Active Pharmaceutical Ingredient (API) industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.